| Income Statement |
| Total Revenue | 20.33K |
|
| Revenues (USD) | 20.33K |
| Cost of Revenue | 39.92K |
| Gross Profit | -19.60K |
| Operating Expenses | 4.49M |
| Research and Development Expense | 1.49M |
| Selling, General and Administrative Expense | 3.00M |
| Operating Income | -4.51M |
| Net Income | -4.46M |
| Net Income Common Stock | -4.46M |
| Net Income Common Stock (USD) | -4.46M |
| Consolidated Income | -4.46M |
| Earnings per Basic Share | -0.28 |
| Earnings per Basic Share (USD) | -0.28 |
| Earnings per Diluted Share | -0.28 |
| Earning Before Interest & Taxes (EBIT) | -4.46M |
| Earning Before Interest & Taxes (USD) | -4.46M |
| Weighted Average Shares | 16.06M |
| Weighted Average Shares Diluted | 16.06M |
| Balance Sheet |
| Cash and Equivalents | 23.47M |
| Cash and Equivalents (USD) | 23.47M |
| Current Assets | 24.27M |
| Property, Plant & Equipment Net | 424.95K |
| Total Assets | 24.93M |
| Debt Current | 72.07K |
| Total Debt | 129.69K |
| Current Liabilities | 1.35M |
| Debt Non-Current | 57.62K |
| Total Liabilities | 1.41M |
| Accumulated Retained Earnings (Deficit) | -15.06M |
| Accumulated Other Comprehensive Income | -28.44K |
| Shareholders Equity | 23.52M |
| Shareholders Equity (USD) | 23.52M |
| Assets Non-Current | 659.65K |
| Total Debt (USD) | 129.69K |
| Deferred Revenue | 2.37K |
| Liabilities Non-Current | 57.62K |
| Trade and Non-Trade Payables | 344.25K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 53.93K |
| Net Cash Flow from Financing | 18.62M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.19M |
| Capital Expenditure | -124.33K |
| Issuance (Purchase) of Equity Shares | 16.02M |
| Issuance (Repayment) of Debt Securities | -870.79K |
| Net Cash Flow from Investing | -124.33K |
| Net Cash Flow from Operations | -4.28M |
| Effect of Exchange Rate Changes on Cash | -26.34K |
| Share Based Compensation | 281.88K |